BRIDGET: Preventing Secondary Brain Metastases in Advanced HER2+ Breast Cancer

Opinion
Video

Carey Anders, MD, offers insights into the BRIDGET trial, a study investigating the role of tucatinib in the prevention of secondary brain metastases in patients with advanced HER2-positive breast cancer.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
      Recent Videos
      Epithelioid Sarcoma: Histological Features and Differential Diagnoses
      Epithelioid Sarcoma: Histological Features and Differential Diagnoses
      Epithelioid Sarcoma: Overview and Presentation
      Epithelioid Sarcoma: Overview and Presentation
      4 experts in this video
      Leveraging PSMA PET Imaging in Posttreatment Response Assessment: Evolving Practices and Data Insights
      4 experts in this video
      Role of PSMA PET Imaging in Guiding Surgical Treatment Decisions in Prostate Cancer
      Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
      Addressing Racial Disparities, Social Barriers to Breast Cancer Care
      4 experts in this video
      PSMA PET Imaging in Biochemical Recurrence: Clinical Approaches and Data-Driven Decisions
      4 experts in this video
      PSMA PET Imaging in Prostate Cancer Staging: Guiding Initial Diagnosis and Treatment Decisions
      5 experts in this video
      The Future of DLBCL: Innovations in Therapy and Patient Care
      4 experts in this video
      Imaging Quality in Prostate Cancer: Impact on Treatment Decision-Making
      4 experts in this video
      Selecting the Optimal PSMA PET Imaging Agent: Clinical Considerations and Data-Driven Decisions
      Related Content
      97 Treatment Discontinuation Among Patients With Stage IV HER2–Negative Breast Cancer

      97 Treatment Discontinuation Among Patients With Stage IV HER2–Negative Breast Cancer

      Chia Jie Tan;Connor Willis;Trang Au;Matthew Schabath, PhD;Chenghui Li;Kristen Kelley;Xiaoqing Xu;Leah Park;Clara Lam;Sandhya Mehta;Jackie Kwong;Diana Brixner;David Stenehjem
      April 17th 2025
      Article
      Paolo Tarantino, MD, and Matteo Lambertini, MD, PhD discuss findings related to CDK4/6 inhibitors and antibody drug conjugates presented at SABCS 2024.

      SABCS 2024 Data Show ‘Great Steps Forward’ in Breast Cancer Care

      Paolo Tarantino, MD;Matteo Lambertini, MD
      January 13th 2025
      Podcast

      Paolo Tarantino, MD, and Matteo Lambertini, MD, PhD discuss findings related to CDK4/6 inhibitors and antibody drug conjugates presented at SABCS 2024.

      TPS 99 Phase 3, Randomized, Open-Label TroFuse-010 Study of Sacituzumab Tirumotecan Alone and With Pembrolizumab Versus Treatment of Physician’s Choice Chemotherapy in Patients With HR+/HER2– Unresectable Locally Advanced or Metastatic Breast Cancer

      TPS 99 Phase 3, Randomized, Open-Label TroFuse-010 Study of Sacituzumab Tirumotecan Alone and With Pembrolizumab Versus Treatment of Physician’s Choice Chemotherapy in Patients With HR+/HER2– Unresectable Locally Advanced or Metastatic Breast Cancer

      Sara M. Tolaney, MD, MPH;Paolo D’Amico;Liyi Jia;Kim M. Hirshfield;Fatima Cardoso
      April 16th 2025
      Article
      A study evaluating disparities in breast reconstructive surgery sought to assess the impact of culture, race, and ethnicity in minority groups.

      Reducing Post-Mastectomy Disparities in Breast Cancer Minority Populations

      Rachel A. Greenup, MD, MPH
      December 23rd 2024
      Podcast

      A study evaluating disparities in breast reconstructive surgery sought to assess the impact of culture, race, and ethnicity in minority groups.

      102 Novel Prognostic and Predictive Locoregional Biosignature for Risk Stratification of Early-Stage Hormone Receptor–Positive Breast Cancer

      102 Novel Prognostic and Predictive Locoregional Biosignature for Risk Stratification of Early-Stage Hormone Receptor–Positive Breast Cancer

      Charlotta Wadsten;Karuna Mittal;Pat W. Whitworth;Chirag Shah, MD;Frank Vicini, MD;Naamit Gerber;Melissa Krystel-Whittemore;Clayton C. Yates;Balasubramanyam Karanam;Walter Bell;Charles E. Cox, MS, FACS;Abigail Beard;Geza Acs;Steven C. Shivers;David J. Dabbs;Jess Savala;Mark Mentrikoski;Troy Bremer
      April 14th 2025
      Article
      Miami Breast Cancer Conference Provided Exciting Updates and Engaging Discussions

      Miami Breast Cancer Conference Provided Exciting Updates and Engaging Discussions

      Neil M. Iyengar, MD
      April 14th 2025
      Article

      Neil M. Iyengar, MD, discussed the most prevalent discussions and exciting updates from the 2025 Miami Breast Cancer Conference.